Reports include patients being labelled as ‘drug addicts’, refused help and referred to social services after disclosing that they use cannabis medicinally.
An increase in self-medicating, further reluctance to prescribe and a potential post code lottery, but overall freedom from stigma and fear?
An expert explores the need for more clinician education around cannabis.
Khiron Europe is confident that its efforts in collecting evidence will allow the UK to follow in the footsteps of Germany’s thriving medical cannabis market.
Patients saw improvements in symptoms and quality of life with cannabis, but less than half spoke to their doctor about it.
Only a tiny fraction of UK medical cannabis patients are accessing the legal market. Why is that and what do we do about it?
A UK cannabis prescriber shares what he has learned on his journey so far.
United Patients Alliance (UPA) will relaunch its campaign at Brighton Medical Cannabis Summit in April.
The UK is poised to become Europe’s second largest medical cannabis market this year.
European cannabis company, Cantourage UK, is bringing the first-ever New Zealand medical cannabis flower to patients, thanks to a partnership with CannFX. The New Zealand-based brand...